Jamie S Miller
CIK 1290697 · Chief Fin & Op Officer · last filed 2026-09-16
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
PYPL price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
2211 N FIRST STREET
SAN JOSE, CA 95131
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PYPL | Chief Fin & Op Officer | 86,408 | $57.14 | $4.94M | -$254.5K | 14 | 2026-09-16 |
| QCOM | Director | 13,066 | $174.37 | $2.28M | $0 | 13 | 2026-03-18 |
| GE | Senior Vice President | 67,594 | $286.68 | $19.38M | $0 | 34 | 2020-02-27 |
| Elevance Health, Inc. (WLP) Delisted | SVP & Chief Accounting Officer | 25,710 | — | — | $0 | 3 | 2008-03-05 |
Recent Filings · Page 7 of 7
64 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2008-04-24 | GE | Grant (A) | — | $0 | EDGAR |
| 2008-03-05 | Elevance Health, Inc. (WLP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-02-08 | Elevance Health, Inc. (WLP) Delisted | Grant (A) | +1,660 | $0 | EDGAR |
| 2007-09-06 | Elevance Health, Inc. (WLP) Delisted | Grant (A) | +24,000 | $1.96M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.